tradingkey.logo

OptimizeRx Corp

OPRX
12.480USD
-0.280-2.19%
收盘 12/26, 16:00美东报价延迟15分钟
232.03M总市值
2888.89市盈率 TTM

OptimizeRx Corp

12.480
-0.280-2.19%

关于 OptimizeRx Corp 公司

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

OptimizeRx Corp简介

公司代码OPRX
公司名称OptimizeRx Corp
上市日期May 18, 2005
CEOSilvestro (Stephen L)
员工数量106
证券类型Ordinary Share
年结日May 18
公司地址260 Charles Street
城市WALTHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02453
电话12486516558
网址https://www.optimizerx.com/
公司代码OPRX
上市日期May 18, 2005
CEOSilvestro (Stephen L)

OptimizeRx Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
139.76K
+3.73%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
76.86K
-2.16%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
74.49K
+19.62%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
69.57K
+3.48%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
46.31K
-2.54%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
30.93K
-26.45%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
14.98K
+193.15%
Mr. Brendan Merrell
Mr. Brendan Merrell
Chief Operating Officer
Chief Operating Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
139.76K
+3.73%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
76.86K
-2.16%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
74.49K
+19.62%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
69.57K
+3.48%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
46.31K
-2.54%

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Whetstone Capital Advisors, LLC
8.09%
Weintraub (Michael)
7.43%
The Vanguard Group, Inc.
5.68%
BlackRock Institutional Trust Company, N.A.
5.67%
Royce Investment Partners
3.63%
其他
69.49%
持股股东
持股股东
占比
Whetstone Capital Advisors, LLC
8.09%
Weintraub (Michael)
7.43%
The Vanguard Group, Inc.
5.68%
BlackRock Institutional Trust Company, N.A.
5.67%
Royce Investment Partners
3.63%
其他
69.49%
股东类型
持股股东
占比
Investment Advisor
34.87%
Investment Advisor/Hedge Fund
22.55%
Individual Investor
16.38%
Hedge Fund
12.09%
Research Firm
4.75%
Pension Fund
0.78%
Bank and Trust
0.14%
Insurance Company
0.04%
其他
8.40%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
268
13.52M
72.70%
-5.62M
2025Q2
261
14.95M
80.84%
-7.34M
2025Q1
267
15.34M
83.16%
-6.19M
2024Q4
295
14.49M
78.68%
-4.45M
2024Q3
303
15.96M
87.07%
-2.38M
2024Q2
340
16.48M
89.93%
-3.43M
2024Q1
347
15.94M
87.64%
-3.60M
2023Q4
378
15.63M
86.21%
-4.61M
2023Q3
399
14.49M
86.61%
-5.94M
2023Q2
406
14.23M
85.34%
-7.19M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Whetstone Capital Advisors, LLC
1.51M
8.12%
--
--
Jun 30, 2025
Weintraub (Michael)
1.38M
7.46%
--
--
Apr 29, 2025
The Vanguard Group, Inc.
920.88K
4.96%
-963.00
-0.10%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.09M
5.89%
-72.63K
-6.23%
Jun 30, 2025
Royce Investment Partners
790.64K
4.26%
-203.66K
-20.48%
Jun 30, 2025
Kennedy Capital Management LLC
472.47K
2.54%
-5.93K
-1.24%
Jun 30, 2025
William Blair & Company, L.L.C. (Research)
628.93K
3.39%
-2.10K
-0.33%
Jun 30, 2025
Rice Hall James & Associates, LLC
607.56K
3.27%
+31.39K
+5.45%
Jun 30, 2025
Febbo (William J)
530.85K
2.86%
-83.11K
-13.54%
Apr 29, 2025
Parkman Healthcare Partners LLC
507.42K
2.73%
+32.42K
+6.83%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
AAM Sawgrass US Small Cap Quality Growth ETF
1.37%
Janus Henderson Small Cap Growth Alpha ETF
0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
0.57%
Even Herd Long Short ETF
0.19%
Vanguard US Multifactor ETF
0.1%
Vanguard US Momentum Factor ETF
0.1%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
查看更多
AAM Sawgrass US Small Cap Quality Growth ETF
占比1.37%
Janus Henderson Small Cap Growth Alpha ETF
占比0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
占比0.57%
Even Herd Long Short ETF
占比0.19%
Vanguard US Multifactor ETF
占比0.1%
Vanguard US Momentum Factor ETF
占比0.1%
iShares Micro-Cap ETF
占比0.06%
Principal U.S. Small-Cap ETF
占比0.05%
Avantis US Small Cap Equity ETF
占比0.03%
iShares Russell 2000 Growth ETF
占比0.02%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

OptimizeRx Corp的前五大股东是谁?

OptimizeRx Corp 的前五大股东如下:
Whetstone Capital Advisors, LLC持有股份:1.51M,占总股份比例:8.12%。
Weintraub (Michael)持有股份:1.38M,占总股份比例:7.46%。
The Vanguard Group, Inc.持有股份:920.88K,占总股份比例:4.96%。
BlackRock Institutional Trust Company, N.A.持有股份:1.09M,占总股份比例:5.89%。
Royce Investment Partners持有股份:790.64K,占总股份比例:4.26%。

OptimizeRx Corp的前三大股东类型是什么?

OptimizeRx Corp 的前三大股东类型分别是:
Whetstone Capital Advisors, LLC
Weintraub (Michael)
The Vanguard Group, Inc.

有多少机构持有OptimizeRx Corp(OPRX)的股份?

截至2025Q3,共有268家机构持有OptimizeRx Corp的股份,合计持有的股份价值约为13.52M,占公司总股份的72.70%。与2025Q2相比,机构持股有所增加,增幅为-8.14%。

哪个业务部门对OptimizeRx Corp的收入贡献最大?

在--,--业务部门对OptimizeRx Corp的收入贡献最大,创收--,占总收入的--%。
KeyAI